Beam Therapeutics Inc. · NASDAQ:BEAM
Evans John M. sold 30,078 Beam Therapeutics Inc. shares (Form 4)
Traded Apr 1, 2026 · Filed Apr 6, 2026
On Apr 1, 2026, Evans John M. (Director, CEO) sold 30,078 Beam Therapeutics Inc. shares at US$24.58 for US$739K under a trading plan, leaving 1,047,205 shares. Filed Apr 6, 2026 (Form 4).
- Sold
- 30,078 shares
- Price
- US$24.58
- Value
- US$739K
- Holding after
- 1,047,205 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Sale | 30,078 | US$24.58 | 1,047,205 | Direct |
Source
Related
- Beam Therapeutics Inc.
- Evans John M.
- Beam Therapeutics Inc. shareholders
- Form 4 · Evans John M. · Oct 16, 2026
- Form 4 · Evans John M. · Jul 1, 2026
- Form 4 · Evans John M. · Apr 1, 2026
- Form 4 · Cavanagh Bethany J · Oct 2, 2026
- Form 4 · Ciaramella Giuseppe · Sep 25, 2026
- Schedule 13G/A · ARK Investment Management LLC · Aug 14, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026
- Form 4 · Simon Amy · Jul 29, 2026